How to Build a Granting Strategy Workshop at the Non-Dilutive Funding Summit
The 21st Non-Dilutive Funding Summit brought together hundreds of life science industry leaders with representatives from some of the leading funding agencies including ARPA-H, BARDA, CPRIT, CIRM, Breakthrough T1D and more, giving attendees the opportunity to learn more in-depth about what non-dilutive funding opportunities are available and relevant for their R&D directly from the funding agencies.
Additionally, the 2025 FreeMind Elite honorees took to the stage to present about their companies research and pipelines and their journey to securing non-dilutive funding.
This free summit is hosted by the FreeMind Group. FreeMind helps companies secure non-dilutive funding for life science R&D and wins over $100 million each year for clients. Follow us on LinkedIn or get our newsletter for news about non-dilutive funding opportunities, announcements about conferences with the best partnering, and discounts for those conferences.
Dr. Alex-Duev Cohen
VP, Client Strategy
Dr. Alexandra Duev-Cohen received her Ph.D. in Immunology and Virology from the Hebrew University of Jerusalem. Her research focused on the interactions between Natural Killer (NK) cells and the different influenza viruses. She identified new ways NK cells can recognize the influenza A viruses and discovered that NK cells are less able to recognize influenza B viruses, thus leading to impaired killing of infected cells. Dr. Duev-Cohen has authored and co-authored numerous publications in immunology and virology-focused peer-reviewed journals and received several awards of excellence.
During her Ph.D. studies, Dr. Duev-Cohen served as a lab manager in charge of writing grant applications, budgeting and allocating funds from grants. As a strategist, she uses her deep knowledge in grants and her scientific expertise in order to match FreeMind clients with the most appropriate non-dilutive fundings.
